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Acetyicholine (1-10/zM) depolarized the membrane and stimulated glucose-induced bursts of electrical ctivity in mouse 
pancreatic B-cells. The acetylcholine effects were mimicked by muscarine while nicotine had no effect on membrane po- 
tential. Pirenzepine, an antagonist ofthe classical M l-type muscarinic receptors, but not gallamine (1-100 gM), an antag- 
onist of the classical M2-type receptors, antagonized the acetylcholine action on glucose-induced electrical ctivity 
(ICs0 =0.25/zM). Bethanechol, anagonist of the classical M2-type musearinic receptors, was approximately 100 times 
less effective than acetylcholine in stimulating the electrical ctivity. In addition, acetylcholine (1/~M) induced amarked 
increase (25%) in input resistance tothe B-cell membrane. The results indicate that acetylcholine exerted its effects on 
the B-cell membrane byinhibiting K+ conductance via activation ofa musearinic receptor subtype distinct from the clas- 
sical M2-type receptor. 
Muscarinic receptor; Acetylcholine; Pirenzepine; Gallamine; (Pancreatic B-cell) 
1. INTRODUCTION 
The autonomic nervous system plays a key role 
in the regulation of glucose-induced insulin secre- 
tion [1,2]. It has been known for some time that 
both stimulation of parasympathetic nerves and 
direct application of acetylcholine (ACh) stimulate 
insulin release [3-5] and glucose-induced lectrical 
activity [6]. 
Although stimulation of both insulin release and 
electrical activity by ACh is widely accepted to take 
place via activation of muscarinic receptors [4,6], 
the detailed mechanisms by which receptor activa- 
tion is coupled to hormone release and plasma 
membrane ion channels are not clear. Stimulated 
Ca 2+ entry has been proposed to be an integral part 
of this sequence of events [6-8]. More recently, 
however, an important role has also been ascribed 
to Ca 2+ mobilization from intracellular stores. 
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This view has gained support from work showing 
that activation of ACh receptors in the B-cell mem- 
brane enhances phosphoinositide turnover, with 
the production of soluble second messengers (e.g. 
inositol 1,4,5-trisphosphate) and mobilization of 
Ca 2+ from intracellular stores [9-13]. 
Historically, muscarinic receptors have been dif- 
ferentiated into two subtypes based upon their af- 
finities for the muscarinic antagonist pirenzepine. 
Thus, classical Ml-type muscarinic receptors have 
high affinity for pirenzepine, while classical 
M2-type muscarinic receptors have low affinity for 
this drug [14,15]. Recently, however, analysis of 
muscarinic receptor genes revealed the existence of 
four distinct receptor types [16-18]. 
Activation of classical M 1-type receptors has 
been generally linked to increased phosphoino- 
sitide turnover [19]; activation of classical M2-type 
receptors, on the other hand, has been associated 
with a decrease in adenylate cyclase activity [19]. 
While some membrane ionic conductances have 
also been shown to be under muscarinic receptor 
control in different systems [20], the particular 
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receptor  subtypes  invo lved  in these in teract ions  are 
genera l ly  unknown.  
In  the  present  s tudy,  we have  character i zed  the  
e lectr ica l  response  o f  the  pancreat ic  B-cel l  mem-  
brane  to cho l inerg ic  s t imu la t ion  w i th  ACh,  and  the 
subtype  o f  muscar in ic  receptor  invo lved  in th is  
response .  
Cell input resistance was measured by intracellular current in- 
jection through the same microelectrode used to measure mem- 
brane potential, as described [23]. 
Acetylcholine chloride, muscarine chloride, nicotine, 
atropine, gaUamine triethiodide, carbamyl-~-methylcholine 
chloride (bethanechol) (all from Sigma Chemical Company, St 
Louis, MO) and pirenzepine (kindly provided by Dr J. Daly, 
NIDDK, NIH) were added to the Krebs solution immediately 
before application to the islets. 
2. MATERIALS  AND METHODS 
Three- to 5-month-old albino mice were used throughout this 
study. The animals were given free access to food and water. 
Pieces of pancreas with partially exposed islets were 
microdissected and used in an in vitro system as described [21]. 
The islets were placed in an 80/zl chamber and perifused at a 
rate of 30/zl/s with a modified Krebs solution containing (mM) 
120 NaC1, 25 NaHCO3, 5 KC1, 2.6 CaC12, 1.1 MgCl2, 11 
glucose, which was equilibrated with 95% Oz/5% CO2 to give 
a pH of 7.4. Experiments were performed at 37°C. 
The islets were impaled with a glass microelectrode in order 
to record the membrane potential from one B-cell which re- 
mained coupled to the other cells in the islet. Potentials were 
measured with two Ag-AgC1 electrodes, one placed in the exter- 
nal solution and the other in the solution filling the microelec- 
trode (1:1 mixture of 1 M K citrate and 3 M KC1). The 
microelectrodes had tip resistances in the range of 150-300 MS/. 
A detailed escription of the electrophysiological methods can 
be found in [22]. 
3. RESULTS 
3.1. Acetylcholine stimulation of  electrical activity 
is mimicked by muscarine 
In  the  presence  o f  g lucose  (11 mM) ,  the  B-cel l  
e lectr ica l  act iv i ty  cons is ted  o f  s low waves  (bursts )  
o f  membrane potent ia l  and  rap id  f luc tuat ions  
(spikes)  ar is ing f rom the  depo lar i zed  (act ive)  phase  
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Fig. 1. Effects of muscarinic and nicotinic receptor activation on 
glucose-induced electrical activity. Membrane potential 
recording from a mouse pancreatic B-cell. The islet was exposed 
sequentially to ACh (A), nicotine (B) and muscarine (C) as 
indicated. Glucose (11 mM) was present continuously. Time 
lapse between each record equal to 5 min. 
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Fig.2. Inhibition of ACh effects on glucose-induced lectrical 
activity by atropine and pirenzepine. (A) ACh was added and 
removed in the continued presence of atropine as indicated. (B) 
Islet was exposed to ACh before (upper ecord), during (middle 
record) and after (lower record) application of pirenzepine. Pre- 
incubation with pirenzepine took 12 min. The third application 
of ACh occurred 12 rain after the removal of pirenzepine. 
Glucose (11 mM) was present continuously. 
412 
Volume 249, number 2 FEBS LETTERS June 1989 
of each burst (fig. 1A, left). Addition of ACh to the 
perifusion medium induced a multiphasic hange 
in the pattern of electrical activity consisting of a 
short period of constant burst activity, which was 
often (but not always) followed by a period of 
reduced electrical activity and then by a phase of 
relatively high burst frequency, about twice that 
recorded in the control period. During this activity 
the membrane potential at the silent phase was 
10-15 mV more positive compared with that in the 
absence of ACh. The size of the ACh-induced 
membrane depolarization was 13 _+ 5 mV in 18 dif- 
ferent cells. The burst frequency of the steady-state 
electrical activity remained high as long as ACh 
was present (longest application time, 20 min). 
Although not immediately apparent from the 
records, the average spike frequency was transient- 
ly enhanced by ACh (not shown). It may also be 
seen (fig. 1A) that removal of ACh led to mem- 
brane hyperpolarization a d to a decrease in burst 
frequency, resulting in the recovery of the pattern 
of burst activity recorded prior to application of 
ACh. In most experiments (12 out of 18), this 
hyperpolarization ccurred concomitantly with a 
transient cessation of electrical activity. 
We have carried out experiments aimed at deter- 
mining whether ACh influenced the electrical ac- 
tivity by activation of muscarinic receptors only, 
or by activation of both muscarinic and nicotinic 
receptors. Nicotine (10/~M), a specific agonist of 
the nicotinic receptor in other preparations, had no 
effect on glucose-induced electrical activity 
(fig.lB). On the other hand, stimulation of the 
muscarinic receptor with a specific ligand, 
muscarine, mimicked the effect obtained with ACh 
(fig. 1C). We conclude that ACh activates glucose- 
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Fig.3. Inhibition of ACh effects on glucose-induced lectrical activity by pirenzepine. (A) Pirenzepine was added and removed in the 
continued presence of ACh as indicated. (B) In two experiments (o, ta), pirenzepine was added at increasingly higher concentrations 
in the continued presence of ACh (1/~M). Time of exposure to each pirenzepine concentration, 6 min. Burst frequency was measured 
from the last 2 min of continuous recording at each concentration f pirenzepine. Also indicated is the pirenzepine concentration 
necessary to reduce burst frequency to half of its control value (ICso). 
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induced electrical activity exclusively via activation 
of muscarinic receptors. 
3.2. Pharmacological dissection of muscarinic 
receptor sub-types involved in ACh action 
Atropine (1/~M), a general inhibitor of 
muscarinic receptors, blocked the stimulatory ef- 
fect of ACh on the electrical activity (fig.2A). 
Likewise, preincubation with pirenzepine, a 
blocker of the classical Ml-type muscarinic recep- 
tors profoundly inhibited the stimulation of elec- 
trical activity brought about by ACh (fig.2B, 
compare middle and upper records). Pirenzepine 
not only impaired the ACh-induced epolarization 
of the membrane, but it also reduced the increase 
in burst frequency by about 85°7o (average of two 
experiments). A third exposure to ACh after 
pirenzepine removal gave an effect similar to that 
obtained during the first control application 
(fig.2B, compare lower to upper record). Thus, the 
lack of ACh effect in the presence of pirenzepine 
is not caused by receptor desensitization. 
The reversal of the ACh effects by pirenzepine 
was further investigated in other experiments, by 
exposing the islets to this antagonist in the presence 
of ACh. An example of one such experiment is il- 
lustrated in fig.3A. Addition of ACh depolarized 
the B-cell membrane and stimulated glucose- 
induced electrical activity as described before. 
Subsequent addition of pirenzepine induced mem- 
brane hyperpolarization a d a transient cessation 
of electrical activity, which eventually reappeared 
with a reduced burst frequency (fig.3A). The dose 
dependence of the pirenzepine effect was in- 
vestigated in two additional experiments, by first 
stimulating the cells with ACh (1/~M), and then 
adding pirenzepine at successively higher concen- 
trations, up to 2.4/~M (not shown). The steady- 
state burst frequency was measured at each con- 
centration and plotted against pirenzepine concen- 
tration (fig.3B). From these plots, the pirenzepine 
concentration necessary to reduce burst frequency 
to control values as about 1.5/zM. Also, the 
pirenzepine concentration for half-maximal inhibi- 
tion of ACh-induced stimulation was 0.25/zM. 
Gallamine, a potent blocker of heart muscarinic 
receptors, has an affinity about 12 times higher for 
classical M2-type muscarinic receptors than for 
Ml-type receptors, and it has accordingly been 
used as an M2-type receptor antagonist [24-26]. 
We have attempted to find evidence for the 
presence of the classical M2-type muscarinic recep- 
tors by undertaking a comparative study of the in- 
hibitory properties of gallamine and pirenzepine. 
Preincubation of the islets with gallamine 
(1/~M) for 10 rain failed to affect he ACh-induced 
stimulation of electrical activity (data not shown). 
In other experiments, addition of gallamine 
(10/~M) did not affect either the burst pattern or 
the membrane potential recorded in the presence 
of ACh (fig.4A). Additional experiments were car- 
ried out in which the islets were challenged with in- 
creasing gallamine concentrations (1-100/~M), in 
the presence of ACh (not shown). From these data, 
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Fig.4. Effect of gallamine on ACh-stimulated lectrical ctivity. 
(A) Gallamine was added and removed in the continued 
presence of ACh as indicated. (B) In additional experiments, 
islets were exposed to gallamine at increasingly higher 
concentrations (1, 10 and 100/~M) for 5 rain in the continued 
presence of ACh. Bars represent the mean steady-state burst 
frequency measured from the last 2 rain of continuous 
recording at each gallamine concentration. Results are 
expressed as°7o of control values (i.e. in 1/~M ACh). AChl, 
1/~M acetylcholine; Gall, I/~M gallamine; Gall0, 10/~M 
gallamine; Gall00, 100/zM gallamine; PZ1, 1/~M pirenzepine. 
Vertical lines represent _+ SD (n = 3 experiments ondifferent 
islets). 
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F ig .5 .  Effects of bethanechol on glucose-induced lectrical activity. (A) ACh (upper ecord) and bethanechol (1, 10 and 100/~M) were 
added and removed as indicated. Each record is the direct continuation of the previous one. (B) Measurements were made and 
expressed asfor fig.4B. AChl, 1/zM acetylcholine; Betl, 1/~M bethanechol; Betl0, 10/~M bethanechol; Betl00, 100/~M bethanechol. 
Vertical ines represent + SD (n = 3 experiments on different islets). 
the steady-state burst frequency was computed and 
plotted against gallamine concentration in the bar 
diagram of fig.4B. For comparison, the inhibitory 
effect of pirenzepine (1/zM) was also included. 
While pirenzepine profoundly inhibited the ACh- 
induced increase in burst frequency, gallamine fail- 
ed to significantly reduce this parameter, at con- 
centrations up to 100/zM (fig.4B). 
We have also compared the relative agonist 
potencies of ACh and bethanechol, an agonist of 
the classical M2-type muscarinic receptor [27], on 
glucose-induced electrical activity. Bethanechol, 
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Fig.6. Effects of ACh on cell input resistance. Brief (0.9 s) hyperpolarizing pulses of current (-0.1 nA) were injected into the cell 
through the same microelectrode used to record membrane potential. Capacitive transients were erased from the record for clarity. 
Cell input resistance values are plotted as a function of time underneath e record. (o) Current injections along the silent phase of 
the bursts; (o) current injections along the active phase. 
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like ACh, induced a dose-dependent decrease in 
the membrane potential at the silent phase of the 
bursts as well as an increase in burst frequency 
(fig.5A). The steady-state burst frequency was 
computed and plotted against bethanechol concen- 
tration in the bar diagram of fig.5B. From these 
data, it can be seen that bethanechol was 100 times 
less potent than ACh in stimulating electrical ac- 
tivity. 
3.3. Effect of ACh on B-cell input resistance 
Muscarinic receptor activation may modulate 
ion channels on the B-cell plasma membrane, thus 
accounting for the membrane depolarization i - 
voked by ACh. If this were the case, a change in 
total membrane conductance should become ap- 
parent. We have tested this hypothesis by measur- 
ing input resistance to the B-cell membrane [23]. 
As illustrated in the record of fig.6, the mem- 
brane responded with downward voltage deflec- 
tions to injections into the cell of brief pulses of 
current with a constant amplitude ( -0 .1  nA) into 
the cell. The cell input resistance was computed 
from each voltage deflection and plotted as a func- 
tion of time under the voltage record shown in 
fig.6. Exposure to ACh first induced a decrease in 
input resistance of approximately 20 MI2, which 
was rapidly superseded by a slowly developing in- 
crease in resistance. This secondary rise, completed 
in 1-2 min, amounted to about 25°7o (two ex- 
periments). 
4. DISCUSSION 
The depolarizing and excitatory effect of 
acetylcholine on the B-cell membrane was mimick- 
ed by muscarine but not by nicotine. Furthermore, 
the membrane response to acetylcholine was block- 
ed by the muscarinic receptor antagonist atropine. 
We conclude, in agreement with previous reports 
[4,6], that acetylcholine exerted its effects on the 
B-cell membrane exclusively via activation of 
muscarinic receptors. 
Our results also show that pirenzepine an- 
tagonized ACh action on glucose-induced elec- 
trical activity. On the other hand, high concen- 
trations of gallamine, an antagonist of the classical 
M2-type muscarinic receptor, failed to antagonize 
the stimulatory effect of acetylcholine. Moreover, 
bethanechol did not have ACh-like effects in the 
low concentration range where it supposedly 
behaves as a selective ligand for classical M2-type 
muscarinic receptors. Taken together these results 
indicate that classical M2-type muscarinic recep- 
tors are not involved in the action of ACh on 
glucose-induced lectrical activity. 
Pirenzepine antagonized the membrane response 
to ACh with an IC5o of 0.25/~M, i.e. a concentra- 
tion far greater than that required for specific ac- 
tivation of brain Ml-type muscarinic receptors 
[15]. While it is possible that the pirenzepine 
binding sites on intact islets of Langerhans are less 
accessible to the drug than those on isolated cells 
or membranes traditionally used for binding 
studies, a more plausible xplanation could be that 
a muscarinic receptor type distinct from the 
classical brain M1- and cardiac M2-subtypes might 
be involved in the B-cell response to ACh. Recent- 
ly, analysis of muscarinic receptor genes have in- 
dicated the existence of four types of muscarinic 
receptors. These are the ml,  m2, m3 and m4 sub- 
types according to the nomenclature put forward 
by Bonner et al. [18]. The m2-subtype, present in 
heart, has a very low affinity for pirenzepine (IC5o 
= 1.3/zM); on the other hand, the ml- and 
m4-subtypes have a very high affinity for 
pirenzepine (IC5o = 35 nM) while the m3-subtype 
shows an intermediate affinity (IC5o = 156 nM). It 
is therefore possible that the B-cell response to 
ACh might be mediated by the m3-subtype of 
muscarinic receptor proposed by Bonner et al. 
[18]. This conclusion is reinforced by the fact that, 
in different mammalian cell lines, m 1- and m3-type 
muscarinic receptors have been found to be 
generally coupled to the phosphoinositide mes- 
senger system. The pancreatic B-cell activation of 
the ACh receptor has also been shown to enhance 
phosphoinositide turnover, with the consequent 
production of inositol 1,4,5-trisphosphate and 
mobilization of Ca 2÷ from intracellular stores 
[9-13]. 
In many cell systems with functional muscarinic 
receptors, a slow membrane depolarization is com- 
monly observed to take place in response to recep- 
tor activation [29]. While in some cells this 
depolarization may occur via activation of either a 
Na ÷ permeability or a non-selective cation 
permeability [30,31], in other cells it may result in- 
stead from a decrease in K ÷ permeability [29-33]. 
Several K ÷ channels in the plasma membrane of 
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Volume 249, number 2 FEBS LETTERS June 1989 
the pancreatic B-cell have been proposed to play a 
key role in both the regulation of membrane poten- 
tial and in the modulat ion of electrical activity 
[34]. Thus, it is possible that the excitatory effect 
of ACh documented in this study may also 
origin~e" from inhibit ion of K ÷ permeabil ity by 
muscarinic receptors. Indeed, we found that ex- 
posure to ACh was accompanied by a marked in- 
crease in input resistance as expected from 
blockade of K + channels. 
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